Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe.
Reactive electrophiles generated by lipid peroxidation are thought to contribute to cardiovascular disease and other oxidative stress-related pathologies by covalently modifying proteins and affecting critical protein functions. The difficulty of capturing and analyzing the relatively small fraction of modified proteins complicates identification of the protein targets of lipid electrophiles. We recently synthesized a biotin-modified linoleoylglycerylphosphatidylcholine probe called PLPBSO ( Tallman et al. Chem. Res. Toxicol. 2007, 20, 227-234 ), which forms typical linoleate oxidation products and covalent adducts with model peptides and proteins. Supplementation of human plasma with PLPBSO followed by free radical oxidation resulted in covalent adduction of PLPBSO to plasma proteins, which were isolated with streptavidin and identified by liquid chromatography-tandem mass spectrometry (LC-MS-MS). Among the most highly modified proteins was apolipoprotein A1 (ApoA1), which is the core component of high density lipoprotein (HDL). ApoA1 phospholipid adduct sites were mapped by LC-MS-MS of tryptic peptides following mild base hydrolysis to release esterified phospholipid adducts. Several carboxylated adducts formed from phospholipid-esterified 9,12-dioxo-10( E)-dodecenoic acid (KODA), 9-hydroxy, 12-oxo-10( E)-dodecenoic acid (HODA), 7-oxoheptanoic acid, 8-oxooctanoic acid, and 9-oxononanoic acid were identified. Free radical oxidations of isolated HDL also generated adducts with 4-hydroxynonenal (HNE) and other noncarboxylated electrophiles, but these were only sporadically identified in the PLPBSO-adducted ApoA1, suggesting a low stoichiometry of modification in the phospholipid-adducted protein. Both phospholipid electrophiles and HNE adducted His162, which resides in an ApoA1 domain involved in the activation of Lecithin-cholesterol acyltransferase and maturation of the HDL particle. ApoA1 lipid electrophile adducts may affect protein functions and provide useful biomarkers for oxidative stress.
Szapacs
Matthew E
ME
Department of Biochemistry, Vanderbilt University, Nashville, Tennessee 37232-0146, USA.
Kim
Hye-Young H
HY
Porter
Ned A
NA
Liebler
Daniel C
DC
D016632:Apolipoprotein A-I / Q000737:chemistry* / Q000378:metabolism; D001710:Biotin / Q000737:chemistry / Q000378:metabolism*; D001798:Blood Proteins / Q000737:chemistry / Q000378:metabolism; D002853:Chromatography, Liquid; D006801:Humans; D015227:Lipid Peroxidation; D013058:Mass Spectrometry; D015335:Molecular Probes / Q000737:chemistry / Q000378:metabolism; D015394:Molecular Structure; D010713:Phosphatidylcholines / Q000737:chemistry* / Q000378:metabolism*; D010743:Phospholipids / Q000737:chemistry / Q000378:metabolism; D010949:Plasma / Q000737:chemistry*
D016632:Apolipoprotein A-I; D001798:Blood Proteins; D015335:Molecular Probes; D010713:Phosphatidylcholines; D010743:Phospholipids; C532858:biotinylated linoleoylglycerylphosphatidylcholine; D001710:Biotin
J Biol Chem. 2002 Oct 11;277(41):38503-16
12105195
J Biol Chem. 2005 Feb 18;280(7):5983-93
15574409
J Pharmacol Exp Ther. 2005 Oct;315(1):8-15
15951401
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
24226387
J Clin Invest. 2003 Mar;111(5):583-93
12618510
Chem Res Toxicol. 2007 Feb;20(2):165-70
17305402
Curr Opin Lipidol. 2006 Aug;17(4):399-403
16832163
Chem Res Toxicol. 2005 Aug;18(8):1219-31
16097795
Science. 2001 Jun 15;292(5524):2083-6
11408659
FASEB J. 1999 Jul;13(10):1157-68
10385607
Chem Res Toxicol. 2007 Feb;20(2):227-34
17305406
J Biol Chem. 2006 Apr 7;281(14):9001-4
16497665
J Biol Chem. 2004 Apr 2;279(14):13447-51
14715668
J Biol Chem. 2002 Oct 11;277(41):38517-23
12145296
Lancet. 1994 Sep 10;344(8924):721-4
7915779
J Proteome Res. 2005 Mar-Apr;4(2):358-68
15822911
Circulation. 2004 Jun 15;109(23 Suppl 1):III8-14
15198960
Chem Res Toxicol. 2007 Jun;20(6):849-53
17489606
Mutat Res. 2001 Apr 18;475(1-2):7-20
11295149
J Biol Chem. 2002 Mar 1;277(9):7010-20
11744722
J Biol Chem. 1999 Aug 27;274(35):24787-98
10455151
Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2248-54
11031211
J Biol Chem. 1997 May 23;272(21):13597-607
9153208
J Biol Chem. 2005 Oct 28;280(43):36386-96
16126721
Pharmacol Rev. 2006 Sep;58(3):342-74
16968945
Chem Res Toxicol. 2007 Jan;20(1):3-5
17226920
Chem Res Toxicol. 2007 May;20(5):767-75
17407328
Physiol Rev. 1998 Apr;78(2):547-81
9562038
Free Radic Biol Med. 2002 Dec 1;33(11):1475-9
12446204
Lipids. 1995 Apr;30(4):277-90
7609594
Chem Res Toxicol. 2003 Jul;16(7):901-11
12870893
J Biol Chem. 1996 Nov 8;271(45):27999-8001
8910407
J Biol Chem. 1999 May 7;274(19):13139-46
10224068
Proteomics. 2007 Feb;7(4):628-640
17309108
Methods Enzymol. 1986;128:155-70
3724500
Proteomics. 2001 Jan;1(1):93-107
11680902
Trends Cardiovasc Med. 2005 Aug;15(6):212-9
16182131
N Engl J Med. 2005 Jul 7;353(1):9-11
16000351
Biochemistry. 2003 Apr 22;42(15):4398-405
12693935
Mol Pharmacol. 2007 Mar;71(3):871-83
17164404
J Clin Invest. 2004 Aug;114(4):529-41
15314690
Science. 1983 Sep 23;221(4617):1256-64
6351251
Free Radic Biol Med. 2005 Mar 15;38(6):698-710
15721980
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6353-8
10339591
J Biol Chem. 2002 Mar 1;277(9):7271-81
11751881
Chem Res Toxicol. 2004 Nov;17(11):1459-67
15540944
Nat Med. 2007 Sep;13(9):1086-95
17721545
Chem Res Toxicol. 2005 Aug;18(8):1324-31
16097806
J Biol Chem. 2005 Oct 7;280(40):33775-84
16091367
Biochemistry. 2006 Sep 5;45(35):10521-8
16939204
Ann N Y Acad Sci. 2005 Jun;1043:396-403
16037261
Nat Struct Mol Biol. 2007 Sep;14(9):861-8
17676061
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1102-11
15790935
Biochemistry. 1999 Oct 26;38(43):14409-15
10572015
Free Radic Res. 2002 Dec;36(12):1307-13
12607822
J Am Soc Mass Spectrom. 1996 Jun;7(6):532-40
24203425
J Biol Chem. 2005 Jan 7;280(1):38-47
15498770
Chem Res Toxicol. 2002 Nov;15(11):1445-50
12437335
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13043-8
12244213
J Biol Chem. 2001 Jun 15;276(24):20831-8
11259420